Popular articles
-
ACR Convergence Is a Nexus of Rheumatology Research, Education, and Community
ACR President Carol A. Langford, MD, MHS, previews the scientific program and special events at ACR Convergence. She also offers tips for attendees.
-
ARP to Celebrate 60th Anniversary at ACR Convergence in Chicago
ARP President Adam Goode, PT, DPT, PhD, shares his excitement about the ARP programming at ACR Convergence during this milestone year.
-
Inaugural Practice Innovation Summit Will Explore Strategies to Build a Thriving Private Practice in an Evolving Healthcare Landscape
The two-day event is designed for clinicians, practice managers, and interprofessional team members in community and private practice settings to gain actionable strategies and expert insights. Chris Phillips, MD, explains what attendees can expect.
-
Pre-Conference Programming, Interactive Learning, and the Latest Advances in Rheumatology Await at ACR Convergence
Annual Meeting Planning Committee Chair Gregory C. Gardner, MD, MACP, shares program highlights participants can look forward to. “It is the science that drives our field forward and improves the lives of our patients, and attendees can expect that to be the focus of the…
-
ACR Convergence 2025 Returns to Chicago, Illinois
Early registration is open through August 21. There are two main registration passes to experience the meeting—All-Access Pass and Scientific Sessions Pass—as well as several add-on options.
-
Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease
Afton Hassett, PhD, delved into the relationship between the psychological impact of rheumatic diseases and their effects on individuals’ physical symptoms and overall well-being. She also discussed effective intervention strategies.
-
ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists
Jamie E. Collins, PhD, defined the types of artificial intelligence rheumatologists might encounter, as well as the potential benefits and risks of this quickly developing technology in healthcare applications.
-
FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases
The U.S. Food and Drug Administration approved indications for adult and pediatric rheumatology as well as new biosimilars and interchangeables for the treatment of rheumatic disease. Erick J. Gapud, MD, PhD, provided an overview of these drugs.
-
Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice
Michael Pfeffer, MD, FACP, discussed his experience piloting technology that utilizes artificial intelligence to listen to real-time conversations between healthcare providers and patients, transcribing the dialogue into text that can become a patient note.
-
Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology
In an opening message to ACR Convergence 2024 attendees, Dwinita Mosby Tyler, PhD, CEO and founder of The Equity Project, LLC, shared ways individuals can advance diversity, equity, and inclusion through education and self-reflection.